The researchers based their findings on patient visits from hospital outpatient clinics in Maryland from 2012 to 2021. Telehealth tools were effective at treating behavioral health conditions, metabolic disorders, dermatology and musculoskeletal disorders, according to a July 12 University of Texas at Austin news release.
Overall, the study did find that telehealth reduced outpatient costs by $239 per patient. However, clinicians could not accurately observe heart and lung conditions or deal with infections over video.
“People believed that telehealth would be the next big thing, the future of healthcare,” Indranil Bardhan, PhD, a professor of information, risk and operations management, said in the release. “But our research shows that its impact is not as straightforward as people might think. It’s more nuanced.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
